Virtu Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Virtu Financial’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,227	Closed	-$264K	–	2376
2018 Q1	$264K	Buy	+4,227	New	+$278K	0.01%	1150
2017 Q4	–	Sell	-10,106	Closed	-$660K	–	2844
2017 Q3	$660K	Buy	+10,106	New	+$638K	0.03%	696
2017 Q1	–	Sell	-8,254	Closed	-$462K	–	534
2016 Q4	$462K	Sell	8,254 -42,347	-84%	-$2.44M	0.05%	264
2016 Q3	$3.12M	Buy	50,601 +34,284	+210%	+$2.25M	0.54%	31
2016 Q2	$1.03M	Sell	16,317 -51,479	-76%	-$3.24M	0.14%	140
2016 Q1	$4.07M	Buy	+67,796	New	+$4.15M	0.57%	39

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial's PJP Position: Q2 2018 in Review

Virtu Financial sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 4,227 shares — an estimated $264K sold.

Virtu Financial first reported a position in PJP in Q1 2016 and held it in 6 quarters. The position peaked at $4.07M in Q1 2016. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Virtu Financial reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Virtu Financial sold 4,227 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $264K.
Virtu Financial first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and held it in 6 quarters.
Virtu Financial's Invesco Pharmaceuticals ETF position peaked at $4.07M in Q1 2016.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.